Spain· ES:60557
REUTENOX 20 mg GRANULADO PARA SUSPENSION ORAL
A tenoxicam product containing tenoxicam, registered in Spain by Laboratorios Rubio S.A.. The same ATC class is registered in 7 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Tenoxicam is registered in 7 of 19 countries.
Countries holding a registration under ATC M01AC02 (tenoxicam), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 6 of them publish a price we can compare per daily dose
Tenoxicam · ATC M01AC02
7 / 19 countries
- Belgiumprice
- Finlandprice
- Franceprice
- Italyprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of tenoxicam costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.30 in Italy to $1.30 in Switzerland — a ×4.4 gap.
- Spain: $0.38 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Tenoxicam · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.30
- FR France$0.44
- ES Spain$0.38
- IT Italy$0.30
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- tenoxicam
- Manufacturer
- Laboratorios Rubio S.A.
- Country
- Spain (ES)
- ATC code
- M01AC02
- ATC class
- Tenoxicam
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo68852320EUR 7.63
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
68 interactions on record for tenoxicam.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tenoxicam · interactions on record
68 records
68 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Tenoxicam in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMobiflex 20mg powder and solvent for solution for injection vialsRoche Products Ltd
- SwitzerlandTilcotil, FilmtablettenViatris Pharma GmbH
- FinlandTilcotilMeda Oy
- FranceTILCOTIL 20 mg, comprimé pelliculé sécableVIATRIS MEDICAL
- ItalyBART*30 cpr rivestite 20 mgSO.SE.PHARM Srl
- BelgiumTilcotil 20 mgViatris Healthcare
- SwedenAlganex 20 mg TablettViatris AB
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Belgium · Tilcotil
- Cyprus · Arthrinal
- France · Tilcotil
- United Kingdom (Northern Ireland) · Tenoxicam Chemidex Pharma, Tenoxicam Ennogen Ip
- Greece · Admiral, Artroxicam
- Italy · Bart
- Luxembourg · Tilcotil
- Portugal · Tenalgin, Tilcotil
- Romania · Neo-Endusix, Tenoxicam Arena
- Sweden · Alganex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8a72f933-23cc-48e0-ac77-bca41b2a36fe GET /v1/drugs/8a72f933-23cc-48e0-ac77-bca41b2a36fe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":791593200000,\"rev\":1751550912000}",
"nregistro": "60557",
"substance": "tenoxicam"
}See everything about tenoxicam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.